Table 1.
Patient characteristics at time of transplantation
| Variables | No PH | PH | P value |
|---|---|---|---|
| Number | 60 (73) | 22 (27) | |
| RVSP, mmHg | 32 (20–39) | 48 (40–74) | |
| Male sex, n (%) | 37 (62) | 11 (50) | 0.34 |
| Age (yrs) | 48 (40–61) | 50 (47–55) | 0.51 |
| BMI | 26 (22–30) | 26 (23–28) | 0.72 |
| Race/ethnicity, n (%) | 0.06 | ||
| White | 37 (62) | 8 (36) | |
| Black | 16 (27) | 8 (36) | |
| Hispanic | 5 (8) | 6 (27) | |
| Asian | 2 (3) | 0 (0) | |
| Systemic HTN, n (%) | 48 (80) | 18 (82) | 0.85 |
| Diabetes mellitus, n (%) | 15 (25) | 8 (36) | 0.31 |
| Hyperlipidemia, n (%) | 17 (28) | 4 (18) | 0.41 |
| COPD, n (%) | 4 (7) | 3 (14) | 0.38 |
| CTD, n (%) | 4 (7) | 1 (5) | 0.99 |
| Left atrial enlargement*, n (%) | 22 (37) | 14 (64) | 0.05 |
| Time echo to transplant, yr | 1.3 (1.3) | 1.8 (1.6) | 0.12 |
| CMV status, n (%) | 0.99 | ||
| donor (−)/recipient (−) | 4 (67) | 1 (5) | |
| donor (− or +)/recipient (+) | 38 (63) | 16 (73) | |
| donor (+)/recipient (−) | 6 (10) | 3 (14) | |
| Transplant type, n (%) | 0.02 | ||
| live donor | 28 (47) | 4 (18) | |
| deceased donor | 32 (53) | 18 (82) | |
| Allograft failure, n (%) | 11 (18) | 9 (41) | 0.02 |
| Time to allograft failure, yr | 2.9 (0.8) | 3.3 (0.8) | 0.75 |
| Death, n (%) | 2 (3) | 1 (5) | 0.80 |
Data are shown as median (interquartile range) or absolute number (%).
*
≥ mild left atrial enlargement on an ordinal scale. BMI=body mass index, HTN=hypertension, COPD=chronic obstructive pulmonary disease, CTD=connective tissue disease, RVSP=right ventricular systolic pressure, CMV=cytomegalovirus